South San Francisco-based Pliant Therapeutics Inx, a clinical stage biopharmaceutical company focused on treating fibrosis, has raised $100 million in Series C financing. Novartis led the financing.
Source: Press Release
Pliant Therapeutics reels in $100m Series C
South San Francisco-based Pliant Therapeutics Inx, a clinical stage biopharmaceutical company focused on treating fibrosis, has raised $100 million in Series C financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: